PharmaShots | Incisive News in 3 Shots

Subscribe Now

metastatic squamous non-small cell lung cancer

Merck's Keytruda (pembrolizumab) + CT Receives NMPA's approval as 1L Treatment for Metastatic Squamous Non-Small Cell Lung Cancer

Merck's Keytruda (pembrolizumab) + CT Receives NMPA's approval as 1L Treatment for Metastatic Squamous Non-Small Cell Lung Cancer

November 26, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us